Eli Lilly promised to lower Insulin prices, but its cheaper drug is hard to find: The Washington Post

Eli Lilly promised to lower Insulin prices, but its cheaper drug is hard to find: The Washington Post

“Each year brings a fresh episode of popular and political outrage over high drug prices,” Christopher Rowland writes for The Washington Post. “In 2019, it was insulin’s turn in the spotlight. The lifesaving drug for diabetics surged in list price more than 250 percent over a recent 10-year span — despite being a century-old invention. The […]

The debate over America’s drug-pricing system is built on myths: STAT

Filed Under: Costs, Health plans, Patients

The debate over America’s drug-pricing system is built on myths: STAT

“America’s drug-pricing system is broken,” writes Matthew Herper on Stat. “Any system in which the list price of insulin triples in a decade, leading patients to ration it and sometimes die, is not working. Cancer patients should not worry that their disease will bankrupt them. The U.S. insurance system, which has instead gone decades without […]